CD19 and rheumatoid arthritis: The regimens for RTX treatment include those derived from the lymphoma protocol (4 weekly doses of 375 mg/m2), rheumatoid arthritis protocol (1 g every 15 days), or low-dose RTX (1 dose of 375 mg/m2 or 100–200 mg repeatedly based on the counts of CD19+ cells).